Ethically Acceptable Compensation for Living Donations of Organs, Tissues, and Cells: An Unexploited Potential?

Applied Health Economics and Health Policy
Trine Tornøe PlatzLars Peter Østerdal

Abstract

The number of living donations of human organs, tissues, and cells falls far short of the need. Market-like arrangements to increase donation rates have been proposed, but they are broadly considered unacceptable due to ethical concerns and are therefore not policy relevant in most countries. The purpose of this paper is to explore a different approach to increasing living donations, namely through the use of ethically acceptable compensation of donors. We review the compensation practices in Europe and find a lack of reimbursement of incurred costs and lack of compensation for non-monetary losses, which create disincentives for donation. We draw on a well-known philosophical theory to explain why donors are rarely fully compensated and why many existing proposals to raise donation rates are seen as controversial or even unethical. We present and discuss three categories of compensation with the potential to increase donation rates in an ethically acceptable way.

References

Jul 13, 1999·Human Reproduction·M H Johnson
Jun 14, 2000·Transplantation·I Fehrman-EkholmG Lundgren
Oct 23, 2001·Journal of Assisted Reproduction and Genetics·K S LeeW W Kim
Jan 10, 2002·Journal of Andrology·Benjamin BartoovYona Barak
Jan 29, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ahad J Ghods
Jun 21, 2002·The New England Journal of Medicine·Francis L DelmonicoStuart J Youngner
May 30, 2003·Cost Effectiveness and Resource Allocation : C/E·Dan W Brock
Feb 21, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Arthur J Matas, Mark Schnitzler
Jan 8, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Ajay K IsraniArthur Caplan
Jan 7, 2006·The Journal of Medicine and Philosophy·Benjamin E Hippen
Apr 28, 2006·The New England Journal of Medicine·Edward A Copelan
Aug 8, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·R S GastonM A Schnitzler
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Ahad J Ghods, Shekoufeh Savaj
May 31, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L E BoulwareN R Powe
Jul 1, 2007·The Journal of Economic Perspectives : a Journal of the American Economic Association·Gary S Becker, Julio Jorge Elias
Jul 29, 2010·Transplantation·UNKNOWN World Health Organization
Jan 1, 2009·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Alena M Buyx
Jan 8, 2011·Transplant International : Official Journal of the European Society for Organ Transplantation·Connie L Davis
Apr 11, 2012·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A S VenkataramaniJ R Wellen
Oct 2, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Lianne BarniehBraden Manns
Dec 4, 2012·Transplant International : Official Journal of the European Society for Organ Transplantation·Annette LennerlingFabienne Dobbels
Jan 3, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J LaveeR Beyar
May 1, 2005·The American Economic Review·Alvin E RothM Utku Ünver
Sep 1, 2009·The American Economic Review·Theodore C BergstromDamien Sheehan-Connor
May 1, 2015·The American Economic Review·Julio J EliasMario Macis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Transplantation Proceedings
T C VooA V Campbell
Health Care Ethics USA : a Publication of the Center for Health Care Ethics
James M DuBois
Journal of the New Jersey Dental Association
Harvey S Nisselson
Current Opinion in Organ Transplantation
Benita S Padilla
© 2022 Meta ULC. All rights reserved